论文部分内容阅读
目的探讨急性冠状动脉综合征(ACS)患者高敏C-反应蛋白(hs-CRP)的表达。方法分别测定60例ACS患者入院时hs-CRP水平,并测定30例稳定型心绞痛及30例健康成人hs-CRP作对照。血浆hs-CRP的测定采用微粒增强免疫透射比浊法。结果ACS组的hs-CRP水平为(8.05±2.48)mg/L,较正常对照组的(2.17±0.91)mg/L高(P<0.05);较稳定型心绞痛组(2.27±0.84)mg/L高(P<0.05),稳定型心绞痛组(2.27±0.84)mg/L较正常对照组(2.17±0.91)mg/L差异无统计学意义(P>0.05)。结论hs-CRP与ACS发生有关,可作为危险分层的指标之一。
Objective To investigate the expression of hs-CRP in patients with acute coronary syndrome (ACS). Methods The hs-CRP levels of 60 ACS patients admitted to hospital were measured. Thirty patients with stable angina pectoris and 30 healthy adults were enrolled as controls. Determination of plasma hs-CRP particle enhanced immunoturbidimetric method. Results The level of hs-CRP in ACS group was (8.05 ± 2.48) mg / L, which was significantly higher than that in normal control group (2.17 ± 0.91 mg / L, P <0.05) L (2.27 ± 0.84) mg / L compared with that of the normal control group (2.17 ± 0.91) mg / L (P> 0.05). Conclusion hs-CRP is associated with the occurrence of ACS and may be used as one of the indicators of risk stratification.